Pub Date : 2025-01-06DOI: 10.3346/jkms.2025.40.e67
Junghee Yoon, Soo-Kyung Cho, Se Rim Choi, Soo-Bin Lee, Juhee Cho, Chan Hong Jeon, Geun-Tae Kim, Jisoo Lee, Yoon-Kyoung Sung
Background: This study aimed to identify key priorities for the development of guidelines for information and communication technology (ICT)-based patient education tailored to the needs of patients with rheumatic diseases (RDs) in the Republic of Korea, based on expert consensus.
Methods: A two-round modified Delphi study was conducted with 20 rheumatology, patient education, and digital health literacy experts. A total of 35 items covering 7 domains and 18 subdomains were evaluated. Each item was evaluated for its level of importance, and the responses were rated on a 4-point Likert scale. Consensus levels were defined as "high" (interquartile range [IQR] ≤ 1, agreement ≥ 80%, content validity ratio [CVR] ≥ 0.7), "Moderate" (IQR ≥ 1, agreement 50-79%, CVR 0.5-0.7), and "Low" (IQR > 1, agreement < 50%, CVR < 0.5).
Results: Strong consensus was reached for key priorities for developing guidelines in areas such as health literacy, digital health literacy, medical terminology, user interface, and user experience design for mobile apps. Chatbot use and video (e.g., YouTube) also achieved high consensus, whereas AI-powered platforms such as ChatGPT showed moderate-to-high agreement. Telemedicine was excluded because of insufficient consensus.
Conclusion: The key priorities identified in this study provide a foundation for the development of ICT-based patient education guidelines for RDs in the Republic of Korea. Future efforts should focus on integrating digital tools into clinical practice to enhance patient engagement and improve clinical outcomes.
{"title":"Expert Consensus on Developing Information and Communication Technology-Based Patient Education Guidelines for Rheumatic Diseases in the Korea.","authors":"Junghee Yoon, Soo-Kyung Cho, Se Rim Choi, Soo-Bin Lee, Juhee Cho, Chan Hong Jeon, Geun-Tae Kim, Jisoo Lee, Yoon-Kyoung Sung","doi":"10.3346/jkms.2025.40.e67","DOIUrl":"https://doi.org/10.3346/jkms.2025.40.e67","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to identify key priorities for the development of guidelines for information and communication technology (ICT)-based patient education tailored to the needs of patients with rheumatic diseases (RDs) in the Republic of Korea, based on expert consensus.</p><p><strong>Methods: </strong>A two-round modified Delphi study was conducted with 20 rheumatology, patient education, and digital health literacy experts. A total of 35 items covering 7 domains and 18 subdomains were evaluated. Each item was evaluated for its level of importance, and the responses were rated on a 4-point Likert scale. Consensus levels were defined as \"high\" (interquartile range [IQR] ≤ 1, agreement ≥ 80%, content validity ratio [CVR] ≥ 0.7), \"Moderate\" (IQR ≥ 1, agreement 50-79%, CVR 0.5-0.7), and \"Low\" (IQR > 1, agreement < 50%, CVR < 0.5).</p><p><strong>Results: </strong>Strong consensus was reached for key priorities for developing guidelines in areas such as health literacy, digital health literacy, medical terminology, user interface, and user experience design for mobile apps. Chatbot use and video (e.g., YouTube) also achieved high consensus, whereas AI-powered platforms such as ChatGPT showed moderate-to-high agreement. Telemedicine was excluded because of insufficient consensus.</p><p><strong>Conclusion: </strong>The key priorities identified in this study provide a foundation for the development of ICT-based patient education guidelines for RDs in the Republic of Korea. Future efforts should focus on integrating digital tools into clinical practice to enhance patient engagement and improve clinical outcomes.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 1","pages":"e67"},"PeriodicalIF":3.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142950248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e308
Sra Jung, Hyejeong Jeon, Mi Yeon Lee, Eunsoo Kim, Dong-Won Shin, Young-Chul Shin, Kang-Seob Oh, Min-Kyoung Kim, Sang-Won Jeon, Sung Joon Cho
Background: This study examined gender differences in occupational stress, depressive symptoms, and suicidal ideation by considering the potential moderating effect of grit on Korean employees.
Methods: A total of 11,369 participants (7,735 men and 3,634 women) aged 19-65 years, employed across 18 private companies and local government organizations in Korea, completed questionnaires including the Short Grit Scale, Korean Occupational Stress Scale, and Center for Epidemiologic Studies Depression Scale between April 2020 and March 2022. Suicidal ideation was assessed based on its presence or absence. Mediation and moderation analyses were performed using the Statistical Package for the Social Sciences PROCESS macro.
Results: Depressive symptoms partially mediated the relationship between occupational stress and suicidal ideation in male employees, whereas depressive symptoms fully mediated the relationship in female employees. Grit moderated the relationship between depressive symptoms and suicidal ideation in male employees but not in female employees. Furthermore, the moderated mediating effect of grit in male employees on the relationship between occupational stress and suicidal ideation provided less protection in cases of severe depression. The cross-sectional design does not allow for causal inferences.
Conclusion: These findings contribute to understanding of the gender differences in the impact of depressive symptoms on the relationship between occupational stress and suicidal ideation, as well as the protective effect of grit. These findings highlight the need for gender-specific approaches to prevent suicidal ideation among employees.
{"title":"Gender Difference of Moderated Mediating Effect of Grit Between Occupational Stress and Suicidal Ideation in Korean Workers.","authors":"Sra Jung, Hyejeong Jeon, Mi Yeon Lee, Eunsoo Kim, Dong-Won Shin, Young-Chul Shin, Kang-Seob Oh, Min-Kyoung Kim, Sang-Won Jeon, Sung Joon Cho","doi":"10.3346/jkms.2024.39.e308","DOIUrl":"10.3346/jkms.2024.39.e308","url":null,"abstract":"<p><strong>Background: </strong>This study examined gender differences in occupational stress, depressive symptoms, and suicidal ideation by considering the potential moderating effect of grit on Korean employees.</p><p><strong>Methods: </strong>A total of 11,369 participants (7,735 men and 3,634 women) aged 19-65 years, employed across 18 private companies and local government organizations in Korea, completed questionnaires including the Short Grit Scale, Korean Occupational Stress Scale, and Center for Epidemiologic Studies Depression Scale between April 2020 and March 2022. Suicidal ideation was assessed based on its presence or absence. Mediation and moderation analyses were performed using the Statistical Package for the Social Sciences PROCESS macro.</p><p><strong>Results: </strong>Depressive symptoms partially mediated the relationship between occupational stress and suicidal ideation in male employees, whereas depressive symptoms fully mediated the relationship in female employees. Grit moderated the relationship between depressive symptoms and suicidal ideation in male employees but not in female employees. Furthermore, the moderated mediating effect of grit in male employees on the relationship between occupational stress and suicidal ideation provided less protection in cases of severe depression. The cross-sectional design does not allow for causal inferences.</p><p><strong>Conclusion: </strong>These findings contribute to understanding of the gender differences in the impact of depressive symptoms on the relationship between occupational stress and suicidal ideation, as well as the protective effect of grit. These findings highlight the need for gender-specific approaches to prevent suicidal ideation among employees.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e308"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e338
Ilke Coskun Benlidayi, Latika Gupta
An editorial article is a type of scholarly communication providing expert views and critical analysis of issues. It may reflect the view of the author(s) or of the organization/journal on a certain topic. An editorial may also comment on a published paper. Editorials are expected to be objective, evidence-based, and informative focusing attention on recent developments and matters of current societal/disciplinary concern. This format allows for timely dissemination of expert insight and facilitates ongoing scholarly discourse. The structure of editorials varies: critical, explanatory, and commendatory types serve varied purposes. Authors of editorials should follow certain principles of academic writing. The aim should be provided in an introductory paragraph. Thereafter, a constructive and balanced critique of the index article and/or a detailed yet concise analyze of the subject of matter should be provided. The conclusion paragraph should include brief take-home messages. Critical arguing should be supported by relevant references. A declaration of any potential conflicts of interests is essential to maintain objectivity and fairness. The current article aims to provide a primer, along with a checklist, on writing editorials.
{"title":"Concise Recommendations for EDitorials: Enhancing Narratives and Composition Effectively (CREDENCE).","authors":"Ilke Coskun Benlidayi, Latika Gupta","doi":"10.3346/jkms.2024.39.e338","DOIUrl":"10.3346/jkms.2024.39.e338","url":null,"abstract":"<p><p>An editorial article is a type of scholarly communication providing expert views and critical analysis of issues. It may reflect the view of the author(s) or of the organization/journal on a certain topic. An editorial may also comment on a published paper. Editorials are expected to be objective, evidence-based, and informative focusing attention on recent developments and matters of current societal/disciplinary concern. This format allows for timely dissemination of expert insight and facilitates ongoing scholarly discourse. The structure of editorials varies: critical, explanatory, and commendatory types serve varied purposes. Authors of editorials should follow certain principles of academic writing. The aim should be provided in an introductory paragraph. Thereafter, a constructive and balanced critique of the index article and/or a detailed yet concise analyze of the subject of matter should be provided. The conclusion paragraph should include brief take-home messages. Critical arguing should be supported by relevant references. A declaration of any potential conflicts of interests is essential to maintain objectivity and fairness. The current article aims to provide a primer, along with a checklist, on writing editorials.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e338"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e337
Jin-Hong Yoo
{"title":"In This Issue on 30-December-2024.","authors":"Jin-Hong Yoo","doi":"10.3346/jkms.2024.39.e337","DOIUrl":"10.3346/jkms.2024.39.e337","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e337"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e335
Sun-Young Jun, Seung-Mo Hong, Kee-Taek Jang
Background: The retinoblastoma (RB) protein which is encoded by RB gene selectively provides a cell type-specific function in malignancies. In colorectal carcinoma, RB has been highly expressed and related cyclin/cyclin-dependent kinase 4/6 inhibitors have shown improved therapeutic effects in some patients. However, little is known about RB in small intestinal adenocarcinoma (SIAC).
Methods: Here, we conducted a multi-institutional study of RB expression in 229 surgically resected SIACs to explore the clinicopathologic and prognostic implications and the relationship with microsatellite instability (MSI) status and KRAS mutations.
Results: High RB expression (RBHigh) was more commonly observed in SIACs (76/229, 33%) than in normal small intestinal mucosa (27/188, 14%; P < 0.001). RBHigh was associated with nodular growth patterns (P = 0.028), the absence of lymphovascular (P = 0.001) and perineural invasion (P = 0.048), and a lower T category (P = 0.042) and indicated better overall survival (P = 0.003). In multivariate analysis, RBHigh (P = 0.049) was an independent prognostic predictor of better prognosis, along with younger patient age (P = 0.049), the absence of retroperitoneal seeding (P = 0.004), lower tumor stage (P < 0.001), and MSI (P = 0.005). The prognostic impact of RB expression was consistently observed regardless of MSI status and specifically persistent in SIACs with lower stages (stages I and II).
Conclusion: RBHigh was related to favorable clinicopathologic SIAC characteristics and indicated better patient prognosis. The prognostic predictability of RB was found in SIACs with lower stages, independent of MSI status. RB expression is a reliable and potent prognostic indicator for SIAC and may aid in selecting chemotherapy for patients.
{"title":"Prognostic Value of Retinoblastoma in Small Intestinal Adenocarcinoma: A Multicenter Retrospective Study.","authors":"Sun-Young Jun, Seung-Mo Hong, Kee-Taek Jang","doi":"10.3346/jkms.2024.39.e335","DOIUrl":"10.3346/jkms.2024.39.e335","url":null,"abstract":"<p><strong>Background: </strong>The retinoblastoma (RB) protein which is encoded by <i>RB</i> gene selectively provides a cell type-specific function in malignancies. In colorectal carcinoma, RB has been highly expressed and related cyclin/cyclin-dependent kinase 4/6 inhibitors have shown improved therapeutic effects in some patients. However, little is known about RB in small intestinal adenocarcinoma (SIAC).</p><p><strong>Methods: </strong>Here, we conducted a multi-institutional study of RB expression in 229 surgically resected SIACs to explore the clinicopathologic and prognostic implications and the relationship with microsatellite instability (MSI) status and <i>KRAS</i> mutations.</p><p><strong>Results: </strong>High RB expression (RB<sup>High</sup>) was more commonly observed in SIACs (76/229, 33%) than in normal small intestinal mucosa (27/188, 14%; <i>P</i> < 0.001). RB<sup>High</sup> was associated with nodular growth patterns (<i>P</i> = 0.028), the absence of lymphovascular (<i>P</i> = 0.001) and perineural invasion (<i>P</i> = 0.048), and a lower T category (<i>P</i> = 0.042) and indicated better overall survival (<i>P</i> = 0.003). In multivariate analysis, RB<sup>High</sup> (<i>P</i> = 0.049) was an independent prognostic predictor of better prognosis, along with younger patient age (<i>P</i> = 0.049), the absence of retroperitoneal seeding (<i>P</i> = 0.004), lower tumor stage (<i>P</i> < 0.001), and MSI (<i>P</i> = 0.005). The prognostic impact of RB expression was consistently observed regardless of MSI status and specifically persistent in SIACs with lower stages (stages I and II).</p><p><strong>Conclusion: </strong>RB<sup>High</sup> was related to favorable clinicopathologic SIAC characteristics and indicated better patient prognosis. The prognostic predictability of RB was found in SIACs with lower stages, independent of MSI status. RB expression is a reliable and potent prognostic indicator for SIAC and may aid in selecting chemotherapy for patients.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e335"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e318
Young Mi Jung, Wonyoung Wi, Kyu-Dong Cho, Su Jung Hong, Min-Jeong Oh, Geum Joon Cho, Joong Shin Park
<p><strong>Background: </strong>The increasing rate of cesarean delivery (CD) is a significant concern in many societies worldwide. Vaginal delivery (VD) is preferred over CD for subsequent pregnancies after successful VD, for women with no specific obstetrical indications, primarily because of concerns about potential complications arising from the surgical procedure. However, the factors that influence the decision of requesting a CD have not yet been thoroughly investigated. This study aimed to examine the underlying reasons that lead mothers to choose CDs in subsequent pregnancies following a VD.</p><p><strong>Methods: </strong>This retrospective study included women who underwent VD in their first pregnancy between 2011 and 2020 and had a second pregnancy and childbirth within the study period. The analysis focused on women eligible for a trial of labor (TOL) in their second pregnancy, excluding those with conditions necessitating a CD. The study defined two groups: the TOL in second pregnancy (TOLS) group, consisting of women with one previous VD who attempted a VD in their subsequent pregnancy; and the CD on maternal request in second pregnancy (CDRS) group, comprising women with one past VD who opted for a CD in their second pregnancy without medical indication. The TOLS and CDRS groups were compared regarding obstetric and neonatal outcomes.</p><p><strong>Results: </strong>During the study period, 372,749 women met the inclusion criteria: 368,311 women in TOLS group and 4,438 women in CDRS group. In the regression analysis for the CDRS, several factors were identified as increasing the risk of choosing CD, including age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.05-1.07), interval between the first and second pregnancies (aOR, 1.32; 95% CI 1.29-1.35), a history of pre-existing hypertension (aOR, 1.76; 95% CI, 1.17-2.65), gestational diabetes mellitus (GDM) during the first pregnancy (aOR, 1.19; 95% CI, 1.05-1.36), hypertensive disease during pregnancy (HDP) (aOR, 1.33; 95% CI, 1.06-1.67), preterm labor during the first pregnancy (aOR, 1.57; 95% CI, 1.32-1.86), postpartum hemorrhage (aOR, 1.33; 95% CI, 1.21-1.47), traumatic event during delivery (aOR, 1.19; 95% CI, 1.12-1.28), surgical VD (aOR, 1.29; 95% CI, 1.19-1.40), and pregnancies with abortive outcomes between the first and second pregnancies (aOR, 1.18; 95% CI, 1.08-1.29). Additionally, women with pre-existing diabetes (aOR, 1.53; 95% CI, 1.24-1.89), pre-existing hypertension (aOR, 1.69; 95% CI, 1.26-2.26), GDM (aOR, 1.23; 95% CI, 1.11-1.37), or HDP (aOR, 2.57; 95% CI, 2.24-2.94) during the second pregnancy continued to exhibit an increased risk of opting for CD even after adjustment.</p><p><strong>Conclusion: </strong>CD after VD was more prevalent among women with certain demographic characteristics and obstetric histories. Investigating the factors influencing women to request CD can be helpful in making informed decisions about safe delivery methods and m
{"title":"Cesarean Delivery Upon Request in Pregnancies Following Vaginal Delivery: A Nationwide Study.","authors":"Young Mi Jung, Wonyoung Wi, Kyu-Dong Cho, Su Jung Hong, Min-Jeong Oh, Geum Joon Cho, Joong Shin Park","doi":"10.3346/jkms.2024.39.e318","DOIUrl":"10.3346/jkms.2024.39.e318","url":null,"abstract":"<p><strong>Background: </strong>The increasing rate of cesarean delivery (CD) is a significant concern in many societies worldwide. Vaginal delivery (VD) is preferred over CD for subsequent pregnancies after successful VD, for women with no specific obstetrical indications, primarily because of concerns about potential complications arising from the surgical procedure. However, the factors that influence the decision of requesting a CD have not yet been thoroughly investigated. This study aimed to examine the underlying reasons that lead mothers to choose CDs in subsequent pregnancies following a VD.</p><p><strong>Methods: </strong>This retrospective study included women who underwent VD in their first pregnancy between 2011 and 2020 and had a second pregnancy and childbirth within the study period. The analysis focused on women eligible for a trial of labor (TOL) in their second pregnancy, excluding those with conditions necessitating a CD. The study defined two groups: the TOL in second pregnancy (TOLS) group, consisting of women with one previous VD who attempted a VD in their subsequent pregnancy; and the CD on maternal request in second pregnancy (CDRS) group, comprising women with one past VD who opted for a CD in their second pregnancy without medical indication. The TOLS and CDRS groups were compared regarding obstetric and neonatal outcomes.</p><p><strong>Results: </strong>During the study period, 372,749 women met the inclusion criteria: 368,311 women in TOLS group and 4,438 women in CDRS group. In the regression analysis for the CDRS, several factors were identified as increasing the risk of choosing CD, including age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.05-1.07), interval between the first and second pregnancies (aOR, 1.32; 95% CI 1.29-1.35), a history of pre-existing hypertension (aOR, 1.76; 95% CI, 1.17-2.65), gestational diabetes mellitus (GDM) during the first pregnancy (aOR, 1.19; 95% CI, 1.05-1.36), hypertensive disease during pregnancy (HDP) (aOR, 1.33; 95% CI, 1.06-1.67), preterm labor during the first pregnancy (aOR, 1.57; 95% CI, 1.32-1.86), postpartum hemorrhage (aOR, 1.33; 95% CI, 1.21-1.47), traumatic event during delivery (aOR, 1.19; 95% CI, 1.12-1.28), surgical VD (aOR, 1.29; 95% CI, 1.19-1.40), and pregnancies with abortive outcomes between the first and second pregnancies (aOR, 1.18; 95% CI, 1.08-1.29). Additionally, women with pre-existing diabetes (aOR, 1.53; 95% CI, 1.24-1.89), pre-existing hypertension (aOR, 1.69; 95% CI, 1.26-2.26), GDM (aOR, 1.23; 95% CI, 1.11-1.37), or HDP (aOR, 2.57; 95% CI, 2.24-2.94) during the second pregnancy continued to exhibit an increased risk of opting for CD even after adjustment.</p><p><strong>Conclusion: </strong>CD after VD was more prevalent among women with certain demographic characteristics and obstetric histories. Investigating the factors influencing women to request CD can be helpful in making informed decisions about safe delivery methods and m","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e318"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.3346/jkms.2024.39.e313
Seo-Yeon Gwak, Jiwon Seo, Go Hun Seo, Jiyoung Oh, Hyun-Jung Lee, Kyu Kim, Iksung Cho, Chi Young Shim, Jong-Won Ha, Geu-Ru Hong
Background: Hypertrophic cardiomyopathy (HCM) needs careful differentiation from other cardiomyopathies. Current guidelines recommend genetic testing, but genetic data on differential diagnoses and their relation with clinical outcomes in HCM are still lacking. This study aimed to investigate the prevalence of genetic variants and the proportion of other cardiomyopathies in patients with suspected HCM in Korea and compare the outcomes of HCM according to the presence of sarcomere gene mutation.
Methods: We enrolled 1,554 patients with suspected HCM having left ventricular hypertrophy on transthoracic echocardiography between April 2012 and February 2023. Patients who declined genetic testing or who had pure apical HCM without a familial history were excluded. Genetic testing was performed using a next-generation sequencing panel or whole-exome sequencing for cardiomyopathies. We performed cardiovascular magnetic resonance if the diagnosis was inconclusive. Genotype-positive HCM was defined as sarcomere gene mutations of pathogenic or likely pathogenic variants. Adverse clinical outcomes were defined as a composite of all-cause death, resuscitated cardiac arrest, heart failure-related admission, appropriate implantable cardioverter defibrillator shocks, and stroke.
Results: Of 492 patients (mean age 49.6 ± 14.7 years, 29.4% women) who underwent genetic testing, 214 (43.5%) had disease-causing gene mutations. After combining gene tests, multi-imaging modality, and clinical information, 447 (90.9%) had HCM, and 27 (5.5%) had Fabry disease. Among the HCM patients, 182 (40.7%) were genotype-positive, and 265 (59.3%) were genotype-negative. Kaplan-Meier curve analysis showed that genotype-positive HCM patients experienced more composite outcomes (log-rank, P < 0.001). In multivariable Cox analysis, non-sustained ventricular tachycardia (NSVT) (hazard ratio [HR], 1.91; 95% confidence interval [CI], 1.17-3.12; P = 0.010), left ventricular ejection fraction (LVEF) < 50% (HR, 5.50; 95% CI, 2.68-11.27; P < 0.001), LA reservoir strain (HR, 0.96; 95% CI, 0.93-0.99; P = 0.037), and positive sarcomere gene mutation (HR, 1.70; 95% CI, 1.04-2.78; P = 0.034) were significantly association with composite outcomes. Sarcomere gene mutation had incremental value for predicting adverse outcomes added on NSVT and LVEF < 50%.
Conclusion: Genetic testing is helpful in diagnosing HCM, and sarcomere gene mutations in HCM are significantly associated with clinical outcomes.
{"title":"Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea.","authors":"Seo-Yeon Gwak, Jiwon Seo, Go Hun Seo, Jiyoung Oh, Hyun-Jung Lee, Kyu Kim, Iksung Cho, Chi Young Shim, Jong-Won Ha, Geu-Ru Hong","doi":"10.3346/jkms.2024.39.e313","DOIUrl":"10.3346/jkms.2024.39.e313","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic cardiomyopathy (HCM) needs careful differentiation from other cardiomyopathies. Current guidelines recommend genetic testing, but genetic data on differential diagnoses and their relation with clinical outcomes in HCM are still lacking. This study aimed to investigate the prevalence of genetic variants and the proportion of other cardiomyopathies in patients with suspected HCM in Korea and compare the outcomes of HCM according to the presence of sarcomere gene mutation.</p><p><strong>Methods: </strong>We enrolled 1,554 patients with suspected HCM having left ventricular hypertrophy on transthoracic echocardiography between April 2012 and February 2023. Patients who declined genetic testing or who had pure apical HCM without a familial history were excluded. Genetic testing was performed using a next-generation sequencing panel or whole-exome sequencing for cardiomyopathies. We performed cardiovascular magnetic resonance if the diagnosis was inconclusive. Genotype-positive HCM was defined as sarcomere gene mutations of pathogenic or likely pathogenic variants. Adverse clinical outcomes were defined as a composite of all-cause death, resuscitated cardiac arrest, heart failure-related admission, appropriate implantable cardioverter defibrillator shocks, and stroke.</p><p><strong>Results: </strong>Of 492 patients (mean age 49.6 ± 14.7 years, 29.4% women) who underwent genetic testing, 214 (43.5%) had disease-causing gene mutations. After combining gene tests, multi-imaging modality, and clinical information, 447 (90.9%) had HCM, and 27 (5.5%) had Fabry disease. Among the HCM patients, 182 (40.7%) were genotype-positive, and 265 (59.3%) were genotype-negative. Kaplan-Meier curve analysis showed that genotype-positive HCM patients experienced more composite outcomes (log-rank, <i>P</i> < 0.001). In multivariable Cox analysis, non-sustained ventricular tachycardia (NSVT) (hazard ratio [HR], 1.91; 95% confidence interval [CI], 1.17-3.12; <i>P</i> = 0.010), left ventricular ejection fraction (LVEF) < 50% (HR, 5.50; 95% CI, 2.68-11.27; <i>P</i> < 0.001), LA reservoir strain (HR, 0.96; 95% CI, 0.93-0.99; <i>P</i> = 0.037), and positive sarcomere gene mutation (HR, 1.70; 95% CI, 1.04-2.78; <i>P</i> = 0.034) were significantly association with composite outcomes. Sarcomere gene mutation had incremental value for predicting adverse outcomes added on NSVT and LVEF < 50%.</p><p><strong>Conclusion: </strong>Genetic testing is helpful in diagnosing HCM, and sarcomere gene mutations in HCM are significantly associated with clinical outcomes.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e313"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-23DOI: 10.3346/jkms.2024.39.e317
Bin Ahn, Seung Hwan Shin, Myung-Jae Hwang, HyoSug Choi, Sara Na, Sangshin Park, Jue Seong Lee, Young June Choe, Yoonsun Yoon, Kyoungsan Seo, Jong Hee Kim, Hyun Mi Kang
Background: This study aimed to investigate the epidemiological characteristics and outcomes of myocarditis/pericarditis after BNT162b2 vaccination in Korean adolescents.
Methods: This was a retrospective cohort analysis of adolescents aged 12-19 years old diagnosed with myocarditis/pericarditis within 42 days of BNT162b2 mRNA vaccination. All reported cases were investigated by city or government epidemiologists and the diagnostic certainty and causality was determined by the Korea Disease Control and Prevention Agency's Adverse Event Following Immunization Expert Advisory Committee according to the modified version of Brighton Collaboration Myocarditis/Pericarditis Working group's case definitions.
Results: A total 3,709,063 adolescents aged 12-19 received 8,135,240 doses of the BNT162b2 vaccine in South Korea, and 184 cases met the Brighton criteria for the case definition of myocarditis and pericarditis with diagnostic certainty of possible and above. The median age was 17 years old (interquartile range [IQR], 15-18) and boys accounted for 81.5% (n = 150/184) of the cases. The overall incidence was 2.25 (95% confidence interval [CI], 1.94-2.60) cases per 100,000 doses and severe cases was 0.25 (95% CI, 0.15-3.80) cases per 100,000 doses. The highest incidence rate was observed in boys after the second dose, with 5.01 (95% CI, 4.12-6.17) cases per 100,000 doses. A total 89.1% (164/184) were classified as mild, and no deaths were reported.
Conclusion: The highest incidence of myocarditis/pericarditis after BNT162b2 immunization was observed in male adolescents after the second dose, with majority of the cases presenting with a mild clinical course and favorable outcome.
{"title":"Epidemiological Characteristics and Outcome of Myocarditis and Pericarditis Temporally Associated With BNT162b2 COVID-19 Vaccine in Adolescents: Korean National Surveillance.","authors":"Bin Ahn, Seung Hwan Shin, Myung-Jae Hwang, HyoSug Choi, Sara Na, Sangshin Park, Jue Seong Lee, Young June Choe, Yoonsun Yoon, Kyoungsan Seo, Jong Hee Kim, Hyun Mi Kang","doi":"10.3346/jkms.2024.39.e317","DOIUrl":"10.3346/jkms.2024.39.e317","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the epidemiological characteristics and outcomes of myocarditis/pericarditis after BNT162b2 vaccination in Korean adolescents.</p><p><strong>Methods: </strong>This was a retrospective cohort analysis of adolescents aged 12-19 years old diagnosed with myocarditis/pericarditis within 42 days of BNT162b2 mRNA vaccination. All reported cases were investigated by city or government epidemiologists and the diagnostic certainty and causality was determined by the Korea Disease Control and Prevention Agency's Adverse Event Following Immunization Expert Advisory Committee according to the modified version of Brighton Collaboration Myocarditis/Pericarditis Working group's case definitions.</p><p><strong>Results: </strong>A total 3,709,063 adolescents aged 12-19 received 8,135,240 doses of the BNT162b2 vaccine in South Korea, and 184 cases met the Brighton criteria for the case definition of myocarditis and pericarditis with diagnostic certainty of possible and above. The median age was 17 years old (interquartile range [IQR], 15-18) and boys accounted for 81.5% (n = 150/184) of the cases. The overall incidence was 2.25 (95% confidence interval [CI], 1.94-2.60) cases per 100,000 doses and severe cases was 0.25 (95% CI, 0.15-3.80) cases per 100,000 doses. The highest incidence rate was observed in boys after the second dose, with 5.01 (95% CI, 4.12-6.17) cases per 100,000 doses. A total 89.1% (164/184) were classified as mild, and no deaths were reported.</p><p><strong>Conclusion: </strong>The highest incidence of myocarditis/pericarditis after BNT162b2 immunization was observed in male adolescents after the second dose, with majority of the cases presenting with a mild clinical course and favorable outcome.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e317"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-23DOI: 10.3346/jkms.2024.39.e331
Kyungmin Huh
{"title":"Addressing the Gaps in Malaria Treatment in Korea.","authors":"Kyungmin Huh","doi":"10.3346/jkms.2024.39.e331","DOIUrl":"10.3346/jkms.2024.39.e331","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e331"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-23DOI: 10.3346/jkms.2024.39.e303
Jin Gyu Lim, Ben Kang, Seak Hee Oh, Eell Ryoo, Yu Bin Kim, Yon Ho Choe, Yeoun Joo Lee, Minsoo Shin, Hye Ran Yang, Soon Chul Kim, Yoo Min Lee, Hong Koh, Ji Sook Park, So Yoon Choi, Su Jin Jeong, Yoon Lee, Ju Young Chang, Tae Hyeong Kim, Jung Ok Shim, Jin Soo Moon
Background: We aimed to investigate the characteristics of pediatric ulcerative colitis (UC) at diagnosis in Korea.
Methods: This was a multicenter, registry-based, inception cohort study conducted in Korea between 2021 and 2023. Children and adolescents newly diagnosed with UC < 18 years were included. Baseline clinicodemographics, results from laboratory, endoscopic exams, and Paris classification factors were collected, and associations between factors at diagnosis were investigated.
Results: A total 205 patients with UC were included. Male-to-female ratio was 1.59:1, and the median age at diagnosis was 14.7 years (interquartile range 11.9-16.2). Disease extent of E1 comprised 12.2% (25/205), E2 24.9% (51/205), E3 11.2% (23/205), and E4 51.7% (106/205) of the patients. S1 comprised 13.7% (28/205) of the patients. The proportion of patients with a disease severity of S1 was significantly higher in patients with E4 compared to the other groups (E1: 0% vs. E2: 2% vs. E3: 0% vs. E4: 24.5%, P < 0.001). Significant differences between disease extent groups were also observed in Pediatric Ulcerative Colitis Activity Index (median 25 vs. 35 vs. 40 vs. 45, respectively, P < 0.001), hemoglobin (median 13.5 vs. 13.2 vs. 11.6 vs. 11.4 g/dL, respectively, P < 0.001), platelet count (median 301 vs. 324 vs. 372 vs. 377 × 10³/μL, respectively, P = 0.001), C-reactive protein (median 0.05 vs. 0.10 vs. 0.17 vs. 0.38 mg/dL, respectively, P < 0.001), and Ulcerative Colitis Endoscopic Index of Severity (median 4 vs. 4 vs. 4 vs. 5, respectively, P = 0.006). No significant differences were observed in factors between groups divided according to sex and diagnosis age.
Conclusion: This study represents the largest multicenter pediatric inflammatory bowel disease cohort in Korea. Disease severity was associated with disease extent in pediatric patients with UC at diagnosis.
Trial registration: Clinical Research Information Service Identifier: KCT0008723.
背景:我们旨在调查韩国儿童溃疡性结肠炎(UC)的诊断特点。方法:这是一项多中心、基于注册的初始队列研究,于2021年至2023年在韩国进行。包括新诊断为UC < 18岁的儿童和青少年。收集基线临床人口学、实验室结果、内窥镜检查和Paris分类因素,并调查诊断时各因素之间的相关性。结果:共纳入205例UC患者。男女比例为1.59:1,诊断时中位年龄为14.7岁(四分位数间距11.9 ~ 16.2)。E1型占12.2% (25/205),E2型占24.9% (51/205),E3型占11.2% (23/205),E4型占51.7%(106/205)。S1占13.7%(28/205)。E4患者中S1严重程度的患者比例明显高于其他组(E1: 0% vs E2: 2% vs E3: 0% vs E4: 24.5%, P < 0.001)。小儿溃疡性结肠炎活动指数(中位数分别为25、35、40、45,P < 0.001)、血红蛋白(中位数分别为13.5、13.2、11.6、11.4 g/dL, P < 0.001)、血小板计数(中位数分别为301、324、372、377 × 10³/μL, P = 0.001)、c反应蛋白(中位数分别为0.05、0.10、0.17、0.38 mg/dL, P < 0.001)、溃疡性结肠炎内镜下严重程度指数(中位数分别为4比4比4比4比5,P = 0.006)。按性别和诊断年龄分组的各因素无显著差异。结论:本研究是韩国最大的多中心儿童炎症性肠病队列研究。在诊断为UC的儿童患者中,疾病严重程度与疾病程度相关。试验注册:临床研究信息服务标识:KCT0008723。
{"title":"Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study.","authors":"Jin Gyu Lim, Ben Kang, Seak Hee Oh, Eell Ryoo, Yu Bin Kim, Yon Ho Choe, Yeoun Joo Lee, Minsoo Shin, Hye Ran Yang, Soon Chul Kim, Yoo Min Lee, Hong Koh, Ji Sook Park, So Yoon Choi, Su Jin Jeong, Yoon Lee, Ju Young Chang, Tae Hyeong Kim, Jung Ok Shim, Jin Soo Moon","doi":"10.3346/jkms.2024.39.e303","DOIUrl":"10.3346/jkms.2024.39.e303","url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate the characteristics of pediatric ulcerative colitis (UC) at diagnosis in Korea.</p><p><strong>Methods: </strong>This was a multicenter, registry-based, inception cohort study conducted in Korea between 2021 and 2023. Children and adolescents newly diagnosed with UC < 18 years were included. Baseline clinicodemographics, results from laboratory, endoscopic exams, and Paris classification factors were collected, and associations between factors at diagnosis were investigated.</p><p><strong>Results: </strong>A total 205 patients with UC were included. Male-to-female ratio was 1.59:1, and the median age at diagnosis was 14.7 years (interquartile range 11.9-16.2). Disease extent of E1 comprised 12.2% (25/205), E2 24.9% (51/205), E3 11.2% (23/205), and E4 51.7% (106/205) of the patients. S1 comprised 13.7% (28/205) of the patients. The proportion of patients with a disease severity of S1 was significantly higher in patients with E4 compared to the other groups (E1: 0% vs. E2: 2% vs. E3: 0% vs. E4: 24.5%, <i>P</i> < 0.001). Significant differences between disease extent groups were also observed in Pediatric Ulcerative Colitis Activity Index (median 25 vs. 35 vs. 40 vs. 45, respectively, <i>P</i> < 0.001), hemoglobin (median 13.5 vs. 13.2 vs. 11.6 vs. 11.4 g/dL, respectively, <i>P</i> < 0.001), platelet count (median 301 vs. 324 vs. 372 vs. 377 × 10³/μL, respectively, <i>P</i> = 0.001), C-reactive protein (median 0.05 vs. 0.10 vs. 0.17 vs. 0.38 mg/dL, respectively, <i>P</i> < 0.001), and Ulcerative Colitis Endoscopic Index of Severity (median 4 vs. 4 vs. 4 vs. 5, respectively, <i>P</i> = 0.006). No significant differences were observed in factors between groups divided according to sex and diagnosis age.</p><p><strong>Conclusion: </strong>This study represents the largest multicenter pediatric inflammatory bowel disease cohort in Korea. Disease severity was associated with disease extent in pediatric patients with UC at diagnosis.</p><p><strong>Trial registration: </strong>Clinical Research Information Service Identifier: KCT0008723.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e303"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}